US Patent 8232371 Modified human interferon polypeptides and their uses
Patent 8232371 was granted and assigned to Ambrx on July, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 8, 2011
Date of Patent
July 31, 2012
Patent Application Number
13315219
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8232371 Modified human interferon polypeptides and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
